Accordingly, Caudell et al. (7) generated transgenic mice (TM) expressing CALM/AF10 under the control of the vav promoter (a pan-hematopoietic vector) and approximately 40-50% of TM developed leukemia at the median age of 12 months. Here, MLLT10 is linked to leukemia.